Publications

Sheehan PJ, Brorby GP, Berman DW, Bogen KT, Holm SE. 2011. Chamber for testing asbestos-containing products: Validation and testing of a re-created chrysotile-containing joint compound.  Ann Occup Hyg 55(7):797-809; doi: 10.1093/annhyg/mer048. PMID: 21795244.

Urban JD, Rowlands JC, Budinsky RA. 2011. Single nucleotide polymorphisms in the human aryl hydrocarbon receptor nuclear translocator (ARNT) gene. Drug Metab Pharmacokinet 26(6):637-645; doi: 10.2133/dmpk.DMPK-11-SC-031. PMID: 21828933.

Bogen KT, Brorby GP, Berman DW, Sheehan PJ, Floyd M. 2011. Measuring mixed cellulose ester (MCE) filter mass under variable humidity conditions.  Ann Occup Hyg 55(5)485-494; doi: 10.1093/annhyg/mer003. PMID: 21430134.

Grace CE, Kim SJ, Rogers JM. 2011. Maternal influences on epigenetic programming of the developing hypothalamic-pituitary-adrenal axis. Birth Defects Res A 91(8):797–805; doi: 10.1002/bdra.20824. PMID: 21656659.

Brorby GP, Sheehan PJ, Berman DW, Bogen KT, Holm SE. 2011. Potential artifacts associated with historical preparation of joint compound samples and reported airborne asbestos concentrations.  J Occup Environ Hyg 8(5):271–278; doi: 10.1080/15459624.2011.566805. PMID: 21462068.

Rowlands JC, Urban JD, Wikoff DS, Budinsky RA. 2011. An evaluation of single nucleotide polymorphisms in the human aryl hydrocarbon receptor-interacting protein (AIP) gene. Drug Metab Pharmacokinet 26(4):431-439; doi: 10.2133/dmpk.DMPK-11-SC-013. PMID: 21512261.

Lau C, Rogers JM, Desai M, Ross MG. 2011. Fetal programming of adult disease: Implications for prenatal care. Obstet Gynecol 117(4):978–985; doi: 10.1097/AOG.0b013e318212140e. PMID: 21422872.

Thompson CM, Grafström RC. 2011. Considerations for the implausibility of leukemia induction by formaldehyde. Toxicol Sci 120(1):230-232; doi: 10.1093/toxsci/kfq340. PMID: 21059796.

Beyer BK, Chernoff N, Danielsson BR, Davis-Bruno K, Harrouk W, Hood RD, Janer G,…, Rogers JM, Scialli AR. 2011. Maternal toxicity and its impact on study design and data interpretation. Birth Defects Res B 92(1):36–51; doi: 10.1002/bdrb.20281. PMID: 21312321.

Thompson CM, Haws LC, Harris MA, Gatto NM, Proctor DM. 2011. Application of the U.S. EPA mode of action framework for purposes of guiding future research: A case study involving the oral carcinogenicity of hexavalent chromium. Toxicol Sci 119(1):20-40; doi: 10.1093/toxsci/kfq320. PMID: 20947717.